Carolyn Hoppe
0000-0001-9213-0547
Publication & Citation Trends
Publications
0 total
A phase 1 study in healthy participants to characterize the safety and pharmacology of inclacumab, a fully human anti-P-selectin antibody, in development for treatment of sickle cell disease OA
Cited by 11
Semantic Scholar
5572697 TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE OA
Cited by 0
Semantic Scholar
TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE OA
Cited by 0
Semantic Scholar
Adjuvant low‐dose ketamine for paediatric and young adult sickle cell vaso‐occlusive episodes in the emergency department
Cited by 1
Semantic Scholar
P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE OA
Cited by 4
Semantic Scholar
Successful Implementation of Newborn Screening for Hemoglobin Disorders in the Philippines OA
Cited by 11
Semantic Scholar
Improvement in the Clinical Global Impression of Change with Voxelotor in Patients with Sickle Cell Disease in the Phase 3 HOPE Trial OA
Cited by 3
Semantic Scholar
Adjuvant low-dose ketamine for pediatric sickle cell vaso-occlusive episodes in the emergency department OA
Cited by 0
Semantic Scholar
Research Topics
Hemoglobinopathies and Related Disorders
(101)
Iron Metabolism and Disorders
(54)
Blood groups and transfusion
(33)
Folate and B Vitamins Research
(19)
Myeloproliferative Neoplasms: Diagnosis and Treatment
(13)
Affiliations
Children's Oncology Group
Boston Children's Hospital
Children’s Institute
New York Blood Center
Longwood University